FDA Inspection 1181513 — Hologic, Inc.
The FDA completed an inspection of Hologic, Inc. on October 14, 2022 in San Diego, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 4 citations were issued during this inspection. Product area: Devices.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- October 14, 2022
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- San Diego, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 3103 | 21 CFR 820.30(i) | Design changes - Lack of or Inadequate Procedures |
| 3191 | 21 CFR 820.30(g) | Design validation - production units |
| 3375 | 21 CFR 820.198(e) | Records of complaint investigation |
| 731 | 21 CFR 803.50(a)(1) | Report of Death or Serious Injury |